StockData
Interpace Biosciences, Inc. logo

Interpace Biosciences, Inc. (IDXG) stock

IDXGOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/30
$5.00−0.15 (-2.91%)

Close on Oct 19, 2026Market cap $138.57MP/E 5.6Yield –

Interpace Biosciences total assets

Total assets on the balance sheet at the end of each period.

Interpace Biosciences's total assets was $34.55M at Jun 30, 2026. For fiscal 2025 it was $33.84M, up 128.8% from the year before. Over ten years it grew -6.3% a year on average. The highest annual figure on record is $124.39M in fiscal 2010.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$33.84M+128.8%
FY2024Dec 31, 2024$14.79M+12.8%
FY2023Dec 31, 2023$13.12M-17.9%
FY2022Dec 31, 2022$15.98M-58.4%
FY2021Dec 31, 2021$38.43M-15.9%
FY2020Dec 31, 2020$45.68M-11.4%
FY2019Dec 31, 2019$51.54M+65.6%
FY2018Dec 31, 2018$31.13M-15.0%
FY2017Dec 31, 2017$36.62M+45.7%
FY2016Dec 31, 2016$25.14M-61.2%
FY2015Dec 31, 2015$64.74M-43.8%
FY2014Dec 31, 2014$115.21M+66.8%
FY2013Dec 31, 2013$69.06M-12.0%
FY2012Dec 31, 2012$78.45M-30.8%
FY2011Dec 31, 2011$113.38M-8.9%
FY2010Dec 31, 2010$124.39M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$34.55M+180.1%
Q1 FY2026Mar 31, 2026$33.41M+130.5%
Q4 FY2025Dec 31, 2025$33.84M+128.8%
Q3 FY2025Sep 30, 2025$12.04M-14.3%
Q2 FY2025Jun 30, 2025$12.34M-4.9%
Q1 FY2025Mar 31, 2025$14.49M+19.4%
Q4 FY2024Dec 31, 2024$14.79M+12.8%
Q3 FY2024Sep 30, 2024$14.04M-1.5%
Q2 FY2024Jun 30, 2024$12.97M-19.2%
Q1 FY2024Mar 31, 2024$12.14M-24.0%
Q4 FY2023Dec 31, 2023$13.12M-17.9%
Q3 FY2023Sep 30, 2023$14.25M-6.8%
Q2 FY2023Jun 30, 2023$16.06M-54.7%
Q1 FY2023Mar 31, 2023$15.98M-58.3%
Q4 FY2022Dec 31, 2022$15.98M-58.4%
Q3 FY2022Sep 30, 2022$15.29M-62.1%
Q2 FY2022Jun 30, 2022$35.49M-17.8%
Q1 FY2022Mar 31, 2022$38.36M-12.5%
Q4 FY2021Dec 31, 2021$38.43M-15.9%
Q3 FY2021Sep 30, 2021$40.31M-20.5%
Q2 FY2021Jun 30, 2021$43.19M-28.8%
Q1 FY2021Mar 31, 2021$43.86M-27.8%
Q4 FY2020Dec 31, 2020$45.68M-11.4%
Q3 FY2020Sep 30, 2020$50.70M-32.1%
Q2 FY2020Jun 30, 2020$60.61M+20.4%
Q1 FY2020Mar 31, 2020$60.78M+11.8%
Q4 FY2019Dec 31, 2019$51.54M+65.6%
Q3 FY2019Sep 30, 2019$74.67M+49.9%
Q2 FY2019Jun 30, 2019$50.33M-2.0%
Q1 FY2019Mar 31, 2019$54.38M+2.4%
Q4 FY2018Dec 31, 2018$31.13M-15.0%
Q3 FY2018Sep 30, 2018$49.80M-1.2%
Q2 FY2018Jun 30, 2018$51.36M-4.4%
Q1 FY2018Mar 31, 2018$53.10M+13.0%
Q4 FY2017Dec 31, 2017$36.62M+45.7%
Q3 FY2017Sep 30, 2017$50.39M+9.6%
Q2 FY2017Jun 30, 2017$53.74M–
Q1 FY2017Mar 31, 2017$46.98M–
Q4 FY2016Dec 31, 2016$25.14M–
Q3 FY2016Sep 30, 2016$45.96M–

More Interpace Biosciences figures

See a number that looks wrong?